Disclaimer: Due to limited levels, errors are inevitable, or some information is not the most timely, welcome to point out.This article is introduced only for medical and health -related drugs, and non -treatment schemes are recommended (if they are involved); this article does not constitute any investment advice.
"This year’s interest and demand from Western Pharmaceuticals have increased significantly." Recently, the four largest CDMO companies in India told the media.In addition, European and American pharmaceutical companies are seeking dependence on India’s CDMO, which is benefiting competitors India.
In recent years, the Indian CDMO industry has developed rapidly with the support of the policy.The Indian research company Mordor Intelligence estimates that the Indian CDMO industry’s revenue this year is US $ 15.6 billion and India is US $ 27.1 billion.However, the company estimates that in the next five years, India’s industrial revenue will grow at an average annual rate of more than 11%to India’s average annual growth rate of about 9.6%.Although the Indian CDMO industry has developed rapidly with national policy support in recent years, and its strength has continued to increase, they must also be careful of Indians to grab orders!
Today I will sort out the CDMO of India’s TOP10.
Divi’s Laboratories LTDJinnai Wealth Management
Divi’s is a public limited company listed on the Indian Stock Exchange, with an income of about $ 1.2B in 2021-22.Divi’s has been established in Haidraba, India for more than 30 yearsKanpur Wealth Management. It has two manufacturing plants. It is one of the top pharmaceutical companies in India."Customized manufacturers" and are one of the world’s top API manufacturers, providing high -quality products with the highest compliance and integrity for more than 100 countries/regions.
Divi’s provides customized synthesis (contract manufacturing services) for global innovation companies and has a wide range of product portfolios in different treatment areas.12 of the top 20 large pharmaceutical companies in the United States, the European Union and Japan have worked with Divi’s for more than 10 years.DIVI has recently realized a milestone as one of the three major API manufacturers in the world and one of the top API companies in Headraba.
Divi’s 20123 fiscal year (2022/4-2023/3) performance shows that net sales 76.2 billion rupees, equivalent to RMB 6.53 billion, decreased by 14%year-on-year.Divi’s sales have declined slightly this year, but the overall upsteps still show a rise.
Divi ’s is under development:
Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) is a contract development and manufacturing organization (CDMO), which provides end -to -end development and manufacturing solutions for the entire drug life cycle.PPS is a subsidiary of Piramal Pharma Limited (PPL). It provides customers with global integrated facilities networks in North America, Europe, and Asia, including drug discovery solutions, crafts and drug development services, clinical trial supply, API’s commercial supply and finished productsDositive form.Provide professional services, such as the development and manufacturing of high -efficiency APIs, antibody drugs, sterile filling/completion, peptide products and services, and powerful solid oral drugs.PPS also provides development and manufacturing services for biological products, including vaccines, gene therapy and monoclonal antibodies.
Piramal Pharma’s 20124 net loss of 990 million rupees in the first quarter of fiscal year, the company reported that the net loss of 1.09 billion rupees in the same period last year.In the first quarter of fiscal year in fiscal year, operating income increased by 18%year -on -year to 17.49 billion rupees.Among them, contract research and manufacturing services (CDMO) revenue increased by 17%year -on -year to 8.98 billion rupees.
Pi Industries LTD
Pi Industries LTD was founded in 1946. It uses a unique business model from the entire agricultural chemical value chain from R & D to distribution to provide innovative solutions through cooperation with the best company.Pi Industries LTD is famous for chemical/engineering -related services and enters the pharmaceutical industry in 2020.
Laurus Labs LTD
Laurus Labs was founded in 2005 and is headquartered in Heidbala, India. It is one of the top ten generic pharmaceutical companies in the world.Laurus Labs has more than 55 advanced R & D laboratories in India and the United States, 8 production factories, with more than 90 API products, and the total capacity of the reactor exceeds 4 million liters.The company’s products are sold to 56 countries, with more than 200 customer groups, more than 750 scientists who have studied more than 4,000 employees, and 264 patents have been submitted, of which 130 patents have been certified.The company’s products are mainly concentrated in anti -reverse virus (ARV), hepatitis C, and tumor drugs.
The latest news disclosed on September 11, 2023 and October 16, 2023, Laurus Labs has successfully completed the acquisition of Laurus Bio Private Limited.Among them, Laurus BIO mainly produces non -animal source reorganization protein, growth factor and cell medium supplements, and also provides precise fermentation professional knowledge for new protein companies and biological manufacturers in medical care, food, nutrition, personal care, and biological base materials markets.CDMO service.
Syngene International LTD
Syngne is a BIOCON Listing Contract Research and Manufacturing Service Subsidon. It is a contract research, development and manufacturing organization (CRDMO). It provides comprehensive discovery, development and manufacturing services for pharmaceutical, biotechnology, animal health, consumer goods and agricultural chemical companies.
Syngene was founded in 1993 and was listed on the Indian Stock Exchange (NSE and BSE) respectively.Syngene has a unique business model, a talent pool composed of more than 6,000 scientists, scientific professional knowledge of new treatment models, experienced management teams and independent board committees to provide services to global customers and provide innovative innovation that benefit human and animal health.Essence
In 1994 and 2000, Ms. Kilan set up two subsidiaries named Syngene and Clinigene. Syngene provided early R & D support services (CRO) in the form of contract research. Clinigene focused on clinical research trials and clinical research trials of generic drugs and new drugs.Development, Clinigeene later merged with Syngene.
Syngene 2023 fiscal year (2022/4-2023/3) performance shows that net sales 32.6 billion rupees, an increase of 23%year-on-year.In the first quarter of fiscal year in fiscal year, operating income increased by 26%year -on -year to 8.32 billion rupees.Increased interest, taxes, depreciation and amortization (EBITDA) increased by 25%year -on -year to 2.35 billion rupees.
Hikal LTD
Founded in 1988, Hikal provided world -class active ingredients, intermediates and R & D services for global pharmaceutical, animal health, biotechnology, crop protection and special chemical companies.
The main businesses include three parts: (1) Drugs: active drug ingredients (API), custom production, intermediate and advanced intermediate.(2) Crop protection: active ingredients, advanced intermediates, intermediates.(3) Craft development, new product development, contract and custom development.
Hikal 2013 (2022/4-2023/3) performance shows that sales were 19.5 billion rupees, a year-on-year increase of 4.2%.
In the second quarter of fiscal year in fiscal year, the operating income was 4.358.7 billion rupeesJaipur Stock. The last quarter was 3.899 billion rupees, which was declining last year.
Aragen Life Sciences
Aragen is a leading R & D and Manufacturing Organization (CRDMO) of a leading small molecule and biological product contract.Aragen has more than 20 years of experience in providing a series of contract research, development and manufacturing services during the entire drug development process, focusing on early discovery and development of new molecular entities (NME).Aragen covers the entire drug development process of small molecules and macromolecular projects.The company has office in eight locations around the world, with about 4,200 employees and more than 450 doctoral degree holders.With his professional knowledge and experience, more than 400 customers (including 6 of the top ten pharmaceutical companies in the world) can promote their research projects from early discovery phase to development and commercialization.Alagen’s innovative thinking, infrastructure, flexible business models, clear goals, and proprietary project management platforms enable it to effectively expand and serve large -scale pharmaceuticals, biotechnology, pesticides and animal health in the world.
Neuland Laboratories LTD
Neuland Laboratories Limited was founded in 1984. It is now a listed company headquartered in Haidlaba, India.Neuland is the leading manufacturer of the active drug component (API), and it is also a end -to -end solution provider that meets the chemical needs of the pharmaceutical industry.Neuland provides a comprehensive solution that meets the chemical requirements of the pharmaceutical industry. From the synthesis of the compound to the clinical life cycle, NCE and senior intermediates are provided at all stages of the clinical life cycle, as well as commercial listing.Its advantage is the professional knowledge of the factory approved by FDA in the United States and high -level intermediates.
For more than 30 years, Neuland has been at the forefront of promoting and accelerating drug development and CGMP production of API.The company’s technology and science team provides comprehensive solutions and services for the global pharmaceutical industry.
JubiLANT LIFE Sciences LTD
JubILANT PHARMOVA LIMITED (formerly JubiLANT LIFE Sciences Limited) is a company with a global business that involves radiation pharmaceuticals, allergies, CDMO sterile injections, contract research and development and manufacturing organizations (CRDMO), generic drugs and patented new drug business.
JubILANT PHARMOVA LIMITED2023 fiscal year (2022/4-2023/3) performance shows: net sales 9.48 billion rupees, an increase of 11.2%year-on-year.
Suven Pharmaceuticals LTD
SUVEN PHARMACEUTILS LTD is a world -class manufacturing facility of drugs and fine chemical intermediate business in the key field of new chemical entities (NCE).SUVEN has established core competitiveness in the field of cyanide and heterochemical chemistry, including pyrimidine, sinosone, azazole, and imidazole. In addition, it also shows its proficiency in carbohydrates and hand chemistry (including tetrahydrofu, amino acids, and yam)And involved in all chemistry fields except fluoride and chemical reactions.Lighting from grade to multiple tons.
Chennai Investment